American Association for Cancer Research

SHERPA: Unknown

People

  1. Robson
    Robson
  2. Offit
    Offit
  3. Norton
    Norton
  4. Berger
    Berger
  5. Mandelker
    Mandelker
  6. Stadler
    Stadler
  7. Solit
    Solit
  8. Hudis
    Hudis
  9. Ladanyi
    Ladanyi
  10. Kemel
    Kemel

Groups

  1. Breast Medicine Service (67)
  2. Department of Medicine (67)
  3. Population Sciences Research Program (67)
  4. Solid Tumor Oncology Division (67)
  5. Survivorship Research (67)
  6. GSK Faculty (38)
  7. Department of Pathology and Laboratory Medicine (28)
  8. Clinical Genetics Service (21)
  9. Epidemiology and Biostatistics (18)
  10. Surgery (18)
Search Within
  1. "Mark Robson"
Formats
  1. Meeting Abstract (45)
  2. Journal Article (22)
Groups
  1. Breast Medicine Service (67)
  2. Department of Medicine (67)
  3. Population Sciences Research Program (67)
  4. Solid Tumor Oncology Division (67)
  5. Survivorship Research (67)
  6. GSK Faculty (38)

More Groups

People
  1. Mark Robson (67)
  2. Kenneth Offit (21)
  3. Larry Norton (11)
  4. Diana Mandelker (10)
  5. Jorge Reis-Filho (10)
  6. Michael Berger (10)

More People

Years
  1. 2023 (1)
  2. 2022 (3)
  3. 2021 (4)
  4. 2020 (14)
  5. 2019 (8)
  6. 2018 (4)

More Years

Publications
  1. Cancer Research (50)
  2. Clinical Cancer Research (17)

Results (67)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • NBN pathogenic germline variants are associated with pan-cancer susceptibility and in vitro DNA damage response defects
    Journal Article

    Belhadj, S.; Khurram, A.; Bandlamudi, C.; Palou-Márquez, G.; Ravichandran, V.; Steinsnyder, Z.; Wildman, T.; Catchings, A.; Kemel, Y.; Mukherjee, S.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Prediction of neoadjuvant treatment outcomes with multimodal data integration in breast cancer
    Meeting Abstract

    Khosravi, P.; Sutton, E. J.; Jee, J.; Dalfonso, T.; Fong, C. J.; Rose, D.; Da Silva, E. M.; Kohli, A.; Ho, D. J.; Ahmed, M. S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Inherited germline cancer susceptibility gene variants in individuals with non-muscle-invasive bladder cancer
    Journal Article

    Pietzak, E. J.; Whiting, K.; Srinivasan, P.; Bandlamudi, C.; Khurram, A.; Joseph, V.; Walasek, A.; Bochner, E.; Clinton, T.; Almassi, N.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Morphologic and genomic characteristics of breast cancers occurring in individuals with Lynch syndrome
    Journal Article

    Schwartz, C. J.; da Silva, E. M.; Marra, A.; Gazzo, A. M.; Selenica, P.; Rai, V. K.; Mandelker, D.; Pareja, F.; Misyura, M.; D'Alfonso, T. M.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Development of a breast cancer risk assessment model for ATM mutation carriers incorporating tyrer-cuzick and a polygenic risk score (PRS)
    Meeting Abstract

    Gallagher, S.; Hughes, E.; Rosenthal, E.; Kurian, A. W.; Domchek, S.; Garber, J.; Probst, B.; Morris, B.; Tshiaba, P.; Roa, B.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • The optimal living and survivorship program: Piloting a novel cancer survivorship care model
    Meeting Abstract

    Corcoran, S.; Russell, J.; Clayton, J.; Smith, A.; Keenan, K.; Robson, M.; Iyengar, N.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • KEYLYNK-009: A phase 2/3, open-label, randomized study of pembrolizumab plus olaparib vs pembrolizumab plus chemotherapy after induction with first-line pembrolizumab plus chemotherapy in patients with locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC)
    Meeting Abstract

    Rugo, H.; Llombart-Cussac, A.; Andre, F.; Robson, M. E.; Saji, S.; Harbeck, N.; Schmid, P.; Cescon, D.; Ahn, J. S.; Nanda, R.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • A phase 1b/2 study of the BET inhibitor ZEN003694 in combination with talazoparib for treatment of patients with TNBC without gBRCA1/2 mutations
    Meeting Abstract

    Aftimos, P.; Oliveira, M.; Punie, K.; Boni, V.; Hamilton, E.; Gucalp, A.; Shah, P.; Mina, L.; Sharma, P.; Bauman, L.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Germline mutation prevalence in young adults with cancer
    Meeting Abstract

    Stadler, Z. K.; Maio, A.; Padunan, A.; Kemel, Y.; Salo-Mullen, E.; Sheehan, M.; Belanfanti, K.; Tejada, P. R.; Birsoy, O.; Mandelker, D.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Genomic methods identify homologous recombination deficiency in pancreas adenocarcinoma and optimize treatment selection
    Journal Article

    Park, W.; Chen, J.; Chou, J. F.; Varghese, A. M.; Yu, K. H.; Wong, W.; Capanu, M.; Balachandran, V.; McIntyre, C. A.; El Dika, I.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: